Angitia Bio is a startup based in China, 1 tracked investor.
Based in China, Angitia Bio is a startup. Brouky records 1 investor associated with the company.
Angitia Bio is a clinical-stage biotechnology company developing innovative biologic therapies for serious musculoskeletal diseases, including osteoporosis and osteogenesis imperfecta.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.